SWOG Update
October 2009
Contents  
Welcome to the October 2009 SWOG Update.

For all members and friends of the Southwest Oncology Group, the SWOG Update will keep you informed of what's happening with the Group. News to report? Send it to communications@swog.org.

View a one-page version for printing.
 
Chair's Corner  
How should we spell success?
Laurence H. Baker photo Questions of how we define success in cancer research and how costs should factor into that definition have been much in the news. [more]

Study Updates  

S0702: Zoledronic acid and ONJ risk
Patients taking zoledronic acid seem to face an increased risk of osteonecrosis of the jaw, or ONJ. S0702 seeks answers. [more]

Dawn Hershman, M.D. S0715: Does ALC prevent neuropathy?
Pain and numbness in hands and feet is a common side effect of taxane-based chemotherapy. Can the dietary supplement acetyl-L-carnitine prevent it? [more]

 
Don't Miss It  
Visualization of MCF-7 genome depicting somatic breast tumor chromosomal rearrangements. (Hampton, et al. Genome Res. 2009 Feb; 19(2); 167-177.) The War on Cancer: Raise the bar, or move the goal line?

Plenary Session
SWOG Fall 2009 Group Meeting
Friday, October 23, 12:15 - 2:45 pm
Gold Level, Regency B - D
Hyatt Regency Chicago
Share |

News from the Genitourinary Committee

Uro-Oncology New Investigators Course to be held at fall Group Meeting

With the goal of recruiting and developing the next generation of senior investigators, the Genitourinary (GU) Committee has set into motion an aggressive plan to provide opportunities for young GU investigators to lead clinical trials, develop new concepts for trials, and participate in the analysis of completed studies. Toward this end, the GU Committee will conduct its fifth Uro-Oncology New Investigators Course in conjunction with SWOG's Fall Group Meeting in October.

The course is targeted to young clinicians with an interest in participating in Group clinical trials, either in institutional practices or as members of the Urologic Cancer Outreach Program (UCOP). Participation is limited and participants are selected by a review process.

Criteria for inclusion include the following:
  • faculty level appointment,
  • potential to participate in Group GU Cancer Committee activities, and/or
  • potential to open a new UCOP within or outside a Southwest Oncology Group institution.

Participants for this year's course will include the following physicians.
  • Konstantinos Arnaoutakis, Arkansas
  • Georg Bartesch, USC UCOP
  • C. Lance Cowley, Baylor
  • Atreya Dash, UC Irvine
  • Nivedita Dhar, Wayne State
  • Tanya Dorff, USC
  • Dragan Golijanin, Rochester
  • Oscar Goodman, Nevada
  • Julie Graff, Oregon
  • Christopher Ledbetter, Tennessee
  • Deva Mahalingam, UTHSCSA
  • Moben Mirza, Kansas
  • Sumanta Pal, City of Hope
  • Stephen Riggs, East Virginia
  • Michael Woods, Loyola

We welcome and encourage the involvement of these future leaders of the committee.


Got news to tell? Send it to communications@swog.org.